AÇIKALIN, A. Et Al. 2019. Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib. CUKUROVA MEDICAL JOURNAL , vol.44, no.2 , 395-401.

AÇIKALIN, A., BAĞIR KILIÇ, E., PAYDAŞ, S., ALSANCAK, P., & ERGİN, M., (2019). Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib. CUKUROVA MEDICAL JOURNAL , vol.44, no.2, 395-401.

AÇIKALIN, ARBİL Et Al. "Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib," CUKUROVA MEDICAL JOURNAL , vol.44, no.2, 395-401, 2019

AÇIKALIN, ARBİL Et Al. "Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib." CUKUROVA MEDICAL JOURNAL , vol.44, no.2, pp.395-401, 2019

AÇIKALIN, A. Et Al. (2019) . "Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib." CUKUROVA MEDICAL JOURNAL , vol.44, no.2, pp.395-401.

@article{article, author={ARBİL AÇIKALIN Et Al. }, title={Chromosomal aberrations in multiple myeloma: clinical outcome and response to bortezomib}, journal={CUKUROVA MEDICAL JOURNAL}, year=2019, pages={395-401} }